Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed)
ID: 356376Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering an R21 exploratory/developmental grant aimed at funding innovative research in the development of organ-on-a-chip (OoC) models for dental, oral, and craniofacial (DOC) applications. The primary objective is to validate these microfluidic systems for disease modeling and pre-clinical efficacy studies, promoting a multidisciplinary approach that integrates fields such as bioengineering and computational biology. This initiative is crucial for enhancing drug testing and improving preclinical models, ultimately leading to better clinical trial designs and reducing reliance on animal testing. The total funding available for FY 2025 is $1 million, with individual awards capped at $275,000 over two years. Applications are due by November 19, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) is offering an R21 exploratory/developmental grant to fund interdisciplinary research aimed at developing organ-on-a-chip (OoC) models specifically for dental, oral, and craniofacial (DOC) applications. The program encourages projects that validate these microfluidic systems for disease modeling and pre-clinical studies, emphasizing the need for a multidisciplinary approach that integrates various fields, such as bioengineering and computational biology. The total funding available for FY 2025 is $1 million to support 3-4 awards, with a budget limit of $275,000 for each applicant over two years. Eligible applicants include a wide range of organizations, from higher education institutions to for-profit and nonprofit entities. Applications are due by November 20, 2024, with reviews anticipated in early 2025. The overall goal is to utilize OoCs to enhance drug testing and improve preclinical models, ultimately leading to better clinical trial design and reduced reliance on animal testing. Key considerations for eligibility and application submission are outlined, with specific emphasis placed on innovative approaches and the expected impact on DOC research.
    Similar Opportunities
    Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)" aimed at advancing the development of organ-on-a-chip (OoC) technologies for dental, oral, and craniofacial research. This initiative seeks to support interdisciplinary research that validates these microfluidic systems for disease modeling and pre-clinical efficacy studies, with the goal of establishing OoC technologies as viable alternatives to animal models. A total of $2 million is allocated for 4-5 grants, with individual project budgets capped at $500,000 annually and a project duration of up to five years. Applications are due by November 19, 2024, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), is offering a funding opportunity titled "Collaborative Science to Achieve Disruptive Innovations in Dental, Oral, and Craniofacial (DOC) Research." This initiative aims to support highly integrated research teams that address significant challenges in the DOC fields through collaborative science, requiring a transdisciplinary approach with three to six principal investigators and a detailed Team Management Plan. The program emphasizes the importance of fostering team science to advance critical research in dental and oral health, with funding available of up to $750,000 per year for a maximum of five years, totaling approximately $3 million annually. Interested applicants can find more information and application details on the NIH website, with a submission deadline of November 19, 2024, and inquiries directed to grantsinfo@nih.gov.
    NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), has announced a funding opportunity for Small Research Grants (R03) aimed at analyzing existing genomic data related to dental, oral, and craniofacial health. This initiative encourages projects that utilize publicly available genomic data and advanced methodologies, focusing on oral health disparities and biological pathways to identify intervention targets. The grant supports projects with budgets up to $200,000 over two years, with applications due by May 7, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development" (R03 Clinical Trial Not Allowed), aimed at supporting innovative research projects that utilize existing dental, oral, or craniofacial databases for secondary statistical analyses or the development of new statistical methodologies. This funding opportunity is particularly focused on studies that do not involve clinical trials and emphasizes the importance of addressing causal relationships in dental and oral health, with a goal of advancing clinical practices and knowledge. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government organizations, with funding available for direct costs up to $100,000 per year, totaling a maximum of $200,000 over two years. Interested parties must submit their applications electronically via Grants.gov by May 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the R21 Exploratory/Developmental Research Grant (PAR-21-167) to support innovative research aimed at developing animal models and related biological materials for biomedical studies. This funding opportunity encourages projects that enhance understanding of human health and diseases by creating models that evaluate multiple body systems or diseases affecting them, rather than focusing on a single disease or NIH Institute. With a funding ceiling of $200,000 available for direct costs over a maximum project duration of two years, eligible applicants include higher education institutions, non-profits, and various governmental organizations. The application deadline is January 7, 2025, and interested parties can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) to support innovative biomedical and clinical research projects. This grant aims to foster exploratory research that may involve significant risks but has the potential for breakthroughs or the development of novel methodologies in health-related fields. The program is crucial for advancing research that addresses pressing health challenges and encourages applications that present new scientific ideas distinct from traditional R01 projects. Eligible applicants include a wide range of institutions, including higher education institutions, nonprofits, and for-profit organizations, both domestic and foreign, with a budget limit of $275,000 over two years and a maximum request of $200,000 in any single year. Interested parties should submit their applications electronically by January 7, 2025, and can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further assistance.
    Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)." This initiative invites applications aimed at improving the utility of mammalian cancer models, including organoids and tumoroids, to better represent human biology and address translational deficiencies in existing models. The funding seeks to advance cancer research by fostering innovative approaches to validate these models and enhance their clinical relevance, ultimately aiming to improve patient outcomes. Eligible applicants can receive up to $499,000 per year for a maximum of five years, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-281.html.
    NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NIDCR Small Grant Program for New Investigators (R03), aimed at supporting early-stage scientists in the fields of oral, dental, and craniofacial research. This grant program is designed for New Investigators who have not previously received substantial independent R01 funding, enabling them to conduct pilot or feasibility studies that will generate preliminary data necessary for future competitive R01 applications. By fostering research in this critical area of public health, the program seeks to empower emerging researchers to address significant questions aligned with the NIDCR's mission. Eligible applicants can request funding of up to $100,000, with a submission deadline of January 25, 2025. For further information, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the program's webpage at http://grants.nih.gov/grants/guide/pa-files/PAR-21-084.html.
    Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Miniaturization and Automation of Tissue Chip Systems" (MATChS), aimed at advancing the development of automated and miniaturized microphysiological systems (MPS) for drug discovery and biomedical research. This funding opportunity encourages U.S. small business concerns (SBCs) to propose innovative solutions that enhance the efficiency and reliability of tissue chip technologies, with a focus on reducing complexity and costs while facilitating higher throughput. Approximately $2.15 million is allocated for FY 2024 to support projects that collaborate with NIH staff to achieve defined milestones and pathways to commercialization. Interested applicants must submit their proposals by February 23, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) to support innovative research projects at the preliminary or conceptual stage, particularly those with the potential to advance biomedical, behavioral, or clinical research. Applicants must include at least one clinical trial in their proposals, focusing on mechanistic studies that align with the scientific missions of participating NIH Institutes and Centers. This funding opportunity is crucial for stimulating novel research that challenges conventional methods and improves clinical practices, with a maximum budget of $275,000 available for a two-year project, and no more than $200,000 allocated in any single year. Interested applicants should adhere to strict submission guidelines and can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance; the application deadline is January 7, 2025.